Logo
Whalesbook
HomeNewsCorporate NewsPremiumStocks
HomeNewsCorporate NewsPremiumStocks

Apollo Hospitals Enterprise Ltd

₹ 7,238-0.44%
16 Jan 4:01 p.m. – close price
🔗apollohospitals.com•BSE: 508869•NSE: APOLLOHOSP
Market Cap₹ 1,04,104 Cr.
Current Price₹ 7,238
High / Low₹ 8,100
Stock P/E74.3
Book Value₹ 648
Dividend Yield0.26 %
ROCE16.4 %
ROE15.1 %
Face Value₹ 5.00
Sales₹ 8,654 Cr.
OPM25.1 %
Mar Cap₹ 1,04,104 Cr.

ABOUT

Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country.Apollo Hospitals has emerged as Asia’s foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies,Primary Care & Diagnostic Clinics and several Retail Health models.[1]

KEY POINTS

Business Segments1) Healthcare Services (50% in H1 FY26 vs 55% in FY22):[1][2][3]The company has a capacity of 10,200 beds in 73 hospitals located in India and overseas, out of which 8,767 beds are located in 45 owned hospitals, 643 beds in Day Surgery & Cradles and 790 beds are in 6 hospitals under management through operations and management contracts.

Also present in buckets:
Aggressive Growth TriggersExcellent ResultsRevenue GuidanceAsset Base ExpansionCapacity Expansion And ProductsPreferential IssuanceLarge Order ReceiptsJv Partnerships AcquisitionsRevenue Guidance Vs ActualsCredit Rating UpdatesRed Flags And Poor Performance

Peer Comparision

S.No.NameCurrent Price (Rs.)Price to EarningMarket Capitalization (Rs.Cr.)Dividend yield (%)Net Profit latest quarter (Rs.Cr.)YOY Quarterly profit growth (%)Sales latest quarter (Rs.Cr.)YOY Quarterly sales growth (%)Return on capital employed (%)Sales (Rs.Cr.)OPM (%)Profit after tax (Rs.Cr.)Profit after tax latest quarter (Rs.Cr.)Price to book valueReturn on assets (%)Debt to equity
1.Apollo Hospitals7238.4574.26104103.570.26419.9013.612356.1010.3416.408654.1025.101401.80419.9011.179.610.34
2.Max Healthcare1035.0071.53100783.660.14491.3074.342135.4725.0714.887941.0926.561409.01491.3010.018.320.33
3.Fortis Health.896.6067.0467533.700.11328.8240.232331.4417.2511.968433.6222.031007.34304.117.186.670.34
4.Narayana Hrudaya1918.7546.1339223.820.23258.4929.641643.7920.2820.755961.0923.53850.33258.169.6612.220.58
5.Aster DM Health.599.3084.6131053.550.83121.3113.831197.2110.2010.684325.2318.61367.05110.246.852.440.46
6.Global Health1140.9051.2530641.260.04158.4021.091099.2214.9119.744004.7523.87597.87158.448.2711.460.25
7.Krishna Institu.612.9574.6624538.320.0072.00-37.45960.7023.5915.003401.6022.98328.6867.1810.818.321.40
–Median: 29 Co.401.051.254084.730.033.2318.47333.2316.0315.411122.3822.9895.3629.835.588.320.34

Quarterly Results

Standalone figures in ₹ crores

Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Sales
1,7161,6391,6411,6881,8661,8241,8951,9372,1352,0552,0752,1682,356
Expenses
1,2631,2221,2181,2711,3871,3741,4441,4661,5951,5431,5541,6221,763
Operating Profit
453417423418479450450471540512521546593
Other Income
43554318655246271211089232141
Profit before tax
346323309282391344312332488449420397554
Tax %
19%24%26%24%25%24%24%24%24%24%21%23%24%
Net Profit
279246227214295263239252370342333307420
EPS in Rs
19.4117.0815.7814.8920.5018.2816.6117.5125.7123.7623.1921.3429.20

Profit & Loss

Standalone Figures in ₹ Crores / Yearly

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales
3,8354,5435,5236,3017,1838,3379,7944,6546,0986,5257,2748,2028,654
Expenses
3,2183,8624,7765,5276,3487,3148,3773,9384,6774,8315,4766,1526,482
Operating Profit
6176817487748351,0221,4187151,4211,6941,7982,0502,172
Other Income
202842678173137131139180342373
Interest
8783134200240268426340244239250254242
Depreciation
129158200241272300482421363367399449484
Profit before tax
420467417359330462682919451,2281,3291,6881,820
Net Profit
3313473342852333034701056651,0851,0101,2961,402
EPS in Rs
23.7724.9124.0020.5016.7621.7633.807.3046.2675.4570.2890.1697.49
Dividend Payout %
24%23%25%29%30%28%18%41%25%20%23%14%–

Compounded Sales Growth

10 Years:6%
5 Years:-3%
3 Years:10%
TTM:11%

Compounded Profit Growth

10 Years:14%
5 Years:28%
3 Years:24%
TTM:25%

Stock Price CAGR

10 Years:18%
5 Years:23%
3 Years:19%
1 Year:7%

Return on Equity

10 Years:11%
5 Years:13%
3 Years:15%
Last Year:15%

Balance Sheet

Standalone figures in ₹ crores

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
70707070707070727272727272
Reserves
2,8953,0923,2463,5093,6243,8143,9195,1306,0396,8537,6398,6629,243
Borrowings
1,0791,6812,3462,7572,9913,2383,1603,0502,7522,5203,2223,0903,133
Other Liabilities
8129781,1768571,1271,3072,9961,4781,5451,3351,4721,5481,719
Total Liabilities
4,8575,8206,8387,1937,8128,42810,1449,72910,40810,78012,40513,37214,167
Fixed Assets
1,9892,4283,0613,6003,7623,9706,0565,0385,1215,0786,0326,3486,417
Gross Block
2,6633,2023,4564,2474,6735,1758,1467,0257,3887,6398,9369,659–
Accumulated Depreciation
6747743956479121,2052,0901,9872,2672,5612,9043,311–
CWIP
4815125363286988192272192496200306390
Investments
6907138771,0649001,0851,0762,0912,0592,2172,6213,9114,402
Other Assets
1,6972,1672,3642,2022,4522,5542,7862,3813,2043,3893,5532,8072,958
Total Assets
4,8575,8206,8387,1937,8128,42810,1449,72910,40810,78012,40513,37214,167

Cash Flows

Standalone Figures in ₹ Crores / Yearly

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity
3033896266325399071,0969161,2011,2241,1911,742
Cash from Investing Activity
-310-681-910-804-378-776-264-781-504-588-835-1,046
Cash from Financing Activity
-40332290130-106-160-771-176-577-779-297-739
Net Cash Flow
-47407-4254-2862-41120-14359-43

Ratios

Standalone Figures in ₹ Crores / Yearly

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days
454436383840369449464136
Inventory Days
485049485247506328192221
Days Payable
45485143454551254124124138134
Cash Conversion Cycle
48463444444235-96-46-59-76-77
Working Capital Days
42432537193-0127273642
ROCE %
13%12%11%9%9%11%13%4%13%16%15%16%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters
29.33%29.33%29.33%29.33%29.33%29.33%29.33%29.33%29.33%29.34%29.34%28.02%28.02%
FIIs
47.94%46.96%47.93%46.15%46.25%45.63%43.92%45.37%45.27%42.74%43.49%44.20%43.54%
DIIs
16.56%17.76%17.02%18.59%18.87%19.55%21.13%19.94%19.97%22.29%21.34%21.12%21.50%
Public
5.94%5.72%5.49%5.68%5.32%5.26%5.38%5.12%5.21%5.41%5.61%6.43%6.71%

* The classifications might have changed from Sep'2022 onwards.ℹ️

BSE Announcements AI Summary

Direct from BSE filings, auto-summarised

Apollo Hospitals to establish multi-speciality hospital in Dwarka, New Delhi

2nd April 2026, 11:45 pm

Apollo Hospitals Subsidiary Acquires 100% Stake in FMCG Firm for ₹9 Lakhs

31st March 2026, 10:09 pm

Apollo Hospitals Completes Acquisition, Raises Stake in AHLL to 99.42%

23rd March 2026, 6:07 pm

Beekay Steel Publishes Financial Results; Apollo Hospitals Diversifies Medical Tourism

16th February 2026, 8:44 pm

Apollo Hospitals Enterprise Ltd: Q3 FY26 Earnings Presentation Transcript Now Available

14th February 2026, 6:00 pm

Published by Other Websites

External media mentions & references

US Tariff Threat Hits Indian Pharma Stocks Hard, Index Down 3%

2nd April 2026, 11:10 am

Nifty Crosses 22,800; IndiGo Soars 8% Amid Geopolitical Watch

1st April 2026, 1:10 pm

FY27 Demergers: Vedanta, Apollo Hospitals to Unlock Investor Value

1st April 2026, 7:26 am

Healthcare Costs Climb, But India's Demand Fuels Apollo's Growth

31st March 2026, 5:53 pm

Apollo Hospitals Boosts Air Ambulance Network for Critical Care

30th March 2026, 1:05 pm

News Articles

Editorial & research coverage

Indian Stocks: Alpha Opportunities Amidst Tech Rout
Indian Stocks: Alpha Opportunities Amidst Tech Rout

14th February 2026, 10:17 am

Corporate Action Surge: 50+ Firms Eye Shareholder Payouts Amid Market Wobble
Corporate Action Surge: 50+ Firms Eye Shareholder Payouts Amid Market Wobble

13th February 2026, 1:31 pm

Apollo Hospitals Surges Post-Q3, Demerger & Expansion Risks Loom
Apollo Hospitals Surges Post-Q3, Demerger & Expansion Risks Loom

12th February 2026, 11:38 am

Hospital Stocks Rally, But Capex Strain and Margin Risks Loom
Hospital Stocks Rally, But Capex Strain and Margin Risks Loom

11th February 2026, 2:22 pm

Q3 Earnings Surge, MSCI Rejig Fuel Indian Markets; Risks Remain
Q3 Earnings Surge, MSCI Rejig Fuel Indian Markets; Risks Remain

11th February 2026, 8:28 am

Documents

Announcements

Board Meeting Intimation for Notice Of The Board Meeting

2h - Board meeting Feb 10, 2026 to approve unaudited results for three and nine months ended Dec 31, 2025.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

5h - Certificate under Regulation 74(5) for the period ended 31st December 2025 enclosed

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Annual Reports

Financial Year 2025

(from bse)

Financial Year 2024

(from bse)

Financial Year 2023

(from bse)

Financial Year 2022

(from bse)

Financial Year 2021

(from bse)

Financial Year 2020

(from bse)

Financial Year 2019

(from bse)

Financial Year 2018

(from bse)

Financial Year 2017

(from bse)

Financial Year 2016

(from bse)

Financial Year 2015

(from bse)

Financial Year 2014

(from bse)

Financial Year 2013

(from bse)

Financial Year 2012

(from bse)

Financial Year 2011

(from bse)

Credit Ratings

Rating update

22 Sep 2025 from crisil

Rating update

9 Jul 2025 from crisil

Rating update

10 Jun 2025 from crisil

Rating update

24 Jan 2025 from fitch

Rating update

11 Jun 2024 from crisil

Rating update

3 May 2024 from crisil

Concalls

Nov 2025

TranscriptPPTRecording

Aug 2025

TranscriptPPTRecording

Jun 2025

TranscriptPPT

May 2025

PPTRecording

May 2025

PPT

Feb 2025

TranscriptPPTRecording

Nov 2024

TranscriptPPTRecording

Aug 2024

TranscriptPPT

May 2024

TranscriptPPTRecording

Apr 2024

PPT

Feb 2024

TranscriptPPTRecording

Nov 2023

TranscriptPPTRecording

Aug 2023

TranscriptPPT

May 2023

TranscriptPPT

Feb 2023

TranscriptPPT

Nov 2022

TranscriptPPT

Aug 2022

TranscriptPPT

May 2022

PPT

Nov 2021

PPT

Aug 2021

TranscriptPPT

Jun 2021

PPT

Jun 2021

PPT

Jun 2021

PPT

Nov 2020

Transcript

Sep 2020

Transcript

Jun 2020

TranscriptPPT

Feb 2020

Transcript

Nov 2019

Transcript

Aug 2019

Transcript

May 2019

TranscriptPPT

Feb 2019

Transcript

Nov 2018

Transcript

Aug 2018

Transcript

May 2018

Transcript

Feb 2018

Transcript

Nov 2017

Transcript

Aug 2017

Transcript

Apr 2017

TranscriptPPT

Nov 2016

Transcript

Feb 2016

Transcript

Nov 2015

PPT

Stock Analysis

Description

Apollo Hospitals Enterprise Limited is a leading integrated healthcare provider in India, operating a network of hospitals, pharmacies, and primary care & diagnostic clinics.

Key Growth Triggers

Apollo Hospitals continues its strategy of expansion and investment in healthcare services. Key growth drivers include capacity expansion, strategic acquisitions, and leveraging its integrated healthcare ecosystem.

Order Book

Currently no data available for Order Book.

Key Red Flags

Currently no data available for Key Red Flags.

Key Dates To Watch

  • February 10, 2026: Board Meeting to approve Q3 FY26 financial results.
  • February 12, 2026: Trading window closure is expected to end 48 hours after results announcement.

Corporate Announcements

2nd Apr 26
Impact Rating: 8
Apollo Hospitals' Board of Directors has approved the establishment of a new multi-speciality hospital in Dwarka, New Delhi, on a 9.33-acre land parcel leased from DDA.
31st Mar 26
Impact Rating: 7
Apollo Hospitals' subsidiary AHL acquired 100% of Apollo Consumer Products for ₹9.00 lakh (₹0.09 cr), enabling its entry into the fast-moving consumer goods (FMCG) business.
23rd Mar 26
Impact Rating: 9
Apollo Hospitals Enterprise Limited completed acquisition of 41,650,638 equity shares in AHLL, raising its stake to 99.42% for Rs. 12,540.68 million.
16th Feb 26
Impact Rating: -
No description available.
14th Feb 26
Impact Rating: 8
Apollo Hospitals Enterprise Ltd announced the availability of its Q3 FY26 earnings presentation transcript, detailing financial results for the period ending December 31, 2025.